Results 101 to 110 of about 351,529 (205)

Evaluation of model‐integrated evidence approaches for pharmacokinetic bioequivalence studies using model averaging methods

open access: yesCPT: Pharmacometrics & Systems Pharmacology
Conventional approaches for establishing bioequivalence (BE) between test and reference formulations using non‐compartmental analysis (NCA) may demonstrate low power in pharmacokinetic (PK) studies with sparse sampling.
Henrik Bjugård Nyberg   +6 more
doaj   +1 more source

The Impact of Differential Cost Sharing of Non-Steroidal Anti-Inflammatory Agents on the Use and Costs of Analgesic Drugs [PDF]

open access: yes
OBJECTIVE: To estimate the effect of differential cost sharing (DCS) schemes for non-steroidal anti-inflammatory drugs (NSAIDs) on drug subsidy program and beneficiary expenditures.
Adrian R. Levy   +5 more
core  

Promoting and regulating generic medicines: Brazil in comparative perspective [PDF]

open access: yes, 2017
Generic drug substitution may constitute a core instrument of countries’ National Pharmaceutical Policies, a way to reduce the price of drugs while expanding access to health care.
Massard da Fonseca, Elize   +1 more
core  

Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective. [PDF]

open access: yesCPT Pharmacometrics Syst Pharmacol, 2023
Manolis E   +10 more
europepmc   +1 more source

Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average prices? [PDF]

open access: yesHealth Econ Rev, 2022
Trujillo AJ   +5 more
europepmc   +1 more source

Validation of Kazakh and Russian Generic Drug Questionnaire. [PDF]

open access: yesMed J Islam Repub Iran
Nakipov Z   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy